Breaking News Instant updates and real-time market news.

ABEO

Abeona Therapeutics

$2.28

(0.00%)

09:46
08/13/19
08/13
09:46
08/13/19
09:46

Abeona Therapeutics price target lowered to $16 from $23 at RBC Capital

RBC Capital analyst Kennen MacKay lowered his price target on Abeona Therapeutics to $16 after its Q2 earnings miss, also reflecting the delay in its EB-101 program and changing in his valuation methodology to discounted cash flow model. The analyst is keeping his Outperform rating on the stock longer term however with a positive view of its in-house manufacturing capabilities and the clinical profile of EB-101.

  • 04

    Sep

ABEO Abeona Therapeutics
$2.28

(0.00%)

07/26/19
MZHO
07/26/19
DOWNGRADE
Target $4
MZHO
Neutral
Abeona Therapeutics downgraded to Neutral from Buy at Mizuho
Mizuho analyst Difei Yang downgraded Abeona Therapeutics to Neutral from Buy with a price target of $4, down from $17, after the company announced a delay in the start of the pivotal EB-101 clinical trial following interactions with FDA, where a number of manufacturing-related issues were raised. This is a negative development for the company with potential implications to other pipeline indications given the crucial importance of manufacturing in gene therapy, Yang tells investors in a research note.
07/26/19
07/26/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dow Inc. (DOW) downgraded to Neutral from Buy at BofA/Merrill with analyst Steve Byrne saying Q2 results were slightly ahead of reduced consensus estimates and the outlook is "underwhelming." 2. Carbonite (CARB) double downgraded to Underweight from Overweight at Barclays and downgraded to Hold from Buy at Craig-Hallum. 3. Abeona Therapeutics (ABEO) downgraded to Neutral from Buy at Mizuho with analyst Difei Yang citing the company's announcement of a delay in the start of the pivotal EB-101 clinical trial following interactions with FDA, where a number of manufacturing-related issues were raised. 4. Masco (MAS) downgraded to Sector Weight from Overweight at KeyBanc with analyst Kenneth Zener saying the risk-reward on the stock has become more balanced following today's 8% rally after the company's Q2 earnings beat. 5. BorgWarner (BWA) downgraded to Sector Perform from Outperform at RBC Capital and to Hold from Buy at Deutsche Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/12/19
CANT
08/12/19
DOWNGRADE
CANT
Neutral
Abeona Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
08/12/19
CANT
08/12/19
DOWNGRADE
Target $2
CANT
Neutral
Cantor Fitzgerald downgrades Abeona, slashes price target to $2 from $29
As previously reported, Cantor Fitzgerald analyst Elemer Piros downgraded Abeona Therapeutics to Neutral from Overweight and slashed his price target on the shares to $2 from $29 following the company's Q2 earnings report. He remains wary of competition for the company's mucopolysaccharidosis IIIA/B and dystrophic epidermolysis bullosa programs and believes Abeona will need to raise money in the next 12 months, Piros tells investors.

TODAY'S FREE FLY STORIES

SQM

SQM

$25.40

-0.86 (-3.27%)

07:45
08/22/19
08/22
07:45
08/22/19
07:45
Downgrade
SQM rating change  »

SQM downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

SEDG

SolarEdge

$87.87

3.16 (3.73%)

07:44
08/22/19
08/22
07:44
08/22/19
07:44
Downgrade
SolarEdge rating change  »

SolarEdge downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$84.51

2.27 (2.76%)

07:43
08/22/19
08/22
07:43
08/22/19
07:43
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:42
08/22/19
08/22
07:42
08/22/19
07:42
Hot Stocks
Dick's Sporting reports Q2 eCommerce sales up 21% »

eCommerce penetration for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

FLR

Fluor

$17.35

0.3 (1.76%)

07:41
08/22/19
08/22
07:41
08/22/19
07:41
Upgrade
Fluor rating change  »

Fluor upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:40
08/22/19
08/22
07:40
08/22/19
07:40
Hot Stocks
Dick's Sporting up 10% after Q2 results beat estimates, FY19 profit view raised »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

PDD

Pinduoduo

$30.14

4.165 (16.04%)

07:39
08/22/19
08/22
07:39
08/22/19
07:39
Recommendations
Pinduoduo analyst commentary  »

Pinduoduo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:38
08/22/19
08/22
07:38
08/22/19
07:38
Earnings
Dick's Sporting says FY19 EPS guidance includes expected tariff impacts »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

TGT

Target

$103.11

17.54 (20.50%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Recommendations
Target analyst commentary  »

Target valuation remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Hot Stocks
Dick's Sporting CEO says 'we are very pleased with our second quarter results' »

"We are very pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HMSY

HMS Holdings

$38.69

-0.19 (-0.49%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Downgrade
HMS Holdings rating change  »

HMS Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:35
08/22/19
08/22
07:35
08/22/19
07:35
Hot Stocks
Dick's Sporting sees FY19 CapEx approximately $230M on gross basis »

In 2019, the company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

CLSD

Clearside Biomedical

$1.27

0.09 (7.66%)

07:35
08/22/19
08/22
07:35
08/22/19
07:35
Hot Stocks
Breaking Hot Stocks news story on Clearside Biomedical »

Clearside Biomedical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:34
08/22/19
08/22
07:34
08/22/19
07:34
Hot Stocks
Dick's Sporting says continuing strategic review of hunt business »

The company is continuing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:33
08/22/19
08/22
07:33
08/22/19
07:33
Hot Stocks
Dick's Sporting sees FY19 SSS growth in 'low single-digits' »

Consolidated same store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:31
08/22/19
08/22
07:31
08/22/19
07:31
Earnings
Dick's Sporting raises FY19 EPS view to $3.30-$3.45 from $3.20-$3.40 

FY19 consensus $3.31.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

PSTG

Pure Storage

$13.87

0.2 (1.46%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Oct

  • 12

    Dec

  • 16

    Dec

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Earnings
Dick's Sporting reports Q2 EPS $1.26, consensus $1.21 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

NBL

Noble Energy

$22.22

-0.02 (-0.09%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Upgrade
Noble Energy rating change  »

Noble Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 02

    Oct

TSLA

Tesla

$220.89

-4.81 (-2.13%)

, TGT

Target

$103.11

17.54 (20.50%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

TSLA

Tesla

$220.89

-4.81 (-2.13%)

TGT

Target

$103.11

17.54 (20.50%)

BCS

Barclays

$6.71

0.025 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 19

    Sep

  • 23

    Sep

  • 25

    Sep

  • 10

    Oct

  • 27

    Oct

FUN

Cedar Fair

$55.07

0.88 (1.62%)

07:28
08/22/19
08/22
07:28
08/22/19
07:28
Upgrade
Cedar Fair rating change  »

Cedar Fair upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

TIF

Tiffany

$84.51

2.27 (2.76%)

07:26
08/22/19
08/22
07:26
08/22/19
07:26
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

NVO

Novo Nordisk

$51.82

0.54 (1.05%)

07:26
08/22/19
08/22
07:26
08/22/19
07:26
Hot Stocks
Novo Nordisk says EC grants extension of indication for Fiasp »

Novo Nordisk announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 25

    Sep

AZN

AstraZeneca

$45.42

0.8 (1.79%)

07:24
08/22/19
08/22
07:24
08/22/19
07:24
Hot Stocks
AstraZeneca agrees to buy FDA Priority Review Voucher from Sobi for $95M »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 16

    Sep

  • 25

    Sep

  • 02

    Oct

AAPL

Apple

$212.69

2.34 (1.11%)

07:23
08/22/19
08/22
07:23
08/22/19
07:23
Periodicals
Apple plans to launch Pro iPhones with 3-sensor camera systems, Bloomberg says »

Apple is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.